Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children
Most Cited Paper
in Malaria Research and Control
18 Months Post-Publication
Class of 2026
“Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
RH5.1/Matrix-M · blood-stage malaria vaccine · Plasmodium falciparum · RH5.1 · Matrix-M adjuvant · Delayed third dose regimen · clinical malaria · anti-RH5.1 serum IgG · growth inhibition activity · vaccine efficacy · seasonal malaria transmission · Rabivax-S · phase 2b trial · pre-erythrocytic vaccines · R21/Matrix-M vaccine · RTS,S/AS01 · blood-stage immunity · intramuscular vaccination · 0, 1, and 5 month regimen · 0, 1, and 2 month regimen
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Malaria Research and Control Papers, Class of 2026. https://pri.pepkio.com/top-papers/malaria-research-and-control/2026. Accessed 2026-07-23. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459